Generalized five‐dimensional dynamic and spectral factor analysis
- 22 March 2006
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 33 (4) , 1016-1024
Abstract
We have generalized the spectral factor analysis and the factor analysis of dynamic sequences (FADS) in SPECTimaging to a five-dimensional general factor analysis model (5D-GFA), where the five dimensions are the three spatial dimensions, photon energy, and time. The generalized model yields a significant advantage in terms of the ratio of the number of equations to that of unknowns in the factor analysis problem in dynamic SPECT studies. We solved the 5D model using a least-squares approach. In addition to the traditional non-negativity constraints, we constrained the solution using a priori knowledge of both time and energy, assuming that primary factors (spectra) are Gaussian-shaped with full-width at half-maximum equal to gamma camera energy resolution. 5D-GFA was validated in a simultaneous pre-/post-synaptic dual isotope dynamic phantom study where Tc 99 m and I 123 activities were used to model early Parkinson disease studies. 5D-GFA was also applied to simultaneous perfusion/dopamine transporter (DAT) dynamic SPECT in rhesus monkeys. In the striatal phantom, 5D-GFA yielded significantly more accurate and precise estimates of both primary Tc 99 m ( bias = 6.4 % ± 4.3 % ) and I 123 ( − 1.7 % ± 6.9 % ) time activity curves (TAC) compared to conventional FADS ( biases = 15.5 % ± 10.6 % in Tc 99 m and 8.3 % ± 12.7 % in I 123 , p < 0.05 ). Our technique was also validated in two primate dynamic dual isotope perfusion/DAT transporter studies. Biases of Tc 99 m -HMPAO and I 123 -DAT activity estimates with respect to estimates obtained in the presence of only one radionuclide (sequential imaging) were significantly lower with 5D-GFA ( 9.4 % ± 4.3 % for Tc 99 m -HMPAO and 8.7 % ± 4.1 % for I 123 -DAT) compared to biases greater than 15% for volumes of interest (VOI) over the reconstructed volumes ( p < 0.05 ) . 5D-GFA is a novel and promising approach in dynamic SPECTimaging that can also be used in other modalities. It allows accurate and precise dynamic analysis while compensating for Compton scatter and cross-talk.Keywords
Funding Information
- National Institutes of Health (EB‐005876)
- National Institutes of Health (RO1‐EB000802)
- National Institutes of Health (EB001989)
- U.S. Department of Energy (DE‐AC02‐05CH11231)
This publication has 13 references indexed in Scilit:
- Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSPMovement Disorders, 2002
- Factor analysis witha prioriknowledge - application in dynamic cardiac SPECTPhysics in Medicine & Biology, 2000
- SPECT imaging of pre- and postsynaptic dopaminergic alterations in l -dopa–untreated PDNeurology, 1999
- Altropane, a SPECT or PET imaging probe for dopamine neurons: II. distribution to dopamine-rich regions of primate brainSynapse, 1998
- Simultaneous dual-radionuclide imaging: are the images trustworthy?European Journal of Nuclear Medicine and Molecular Imaging, 1996
- Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human SubjectsJournal of Cerebral Blood Flow & Metabolism, 1994
- Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonismNuclear Medicine Communications, 1994
- Target apex-seeking in factor analysis of medical image sequencesPhysics in Medicine & Biology, 1993
- Background correction in factor analysis of dynamic scintigraphic studies: necessity and implementationPhysics in Medicine & Biology, 1990
- On the existence of an unambiguous solution in factor analysis of dynamic studiesPhysics in Medicine & Biology, 1989